immunotherapy

Cidara’s J&J-partnered immunotherapy could target flu and cancer
Cidara’s J&J-partnered immunotherapy could target flu and cancer
Pharma Voice
Cidara
JNJ
immunotherapy
drug-Fc conjugates
cancer
Flu
Flag link:
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
Flag link:
Sellas celebrates positive Phase I results in lung cancer
Sellas celebrates positive Phase I results in lung cancer
Clinical Trials Arena
Sellas
clinical trials
immunotherapy
Opdivo
mesothelioma
lung cancer
Flag link:
Prime and Cimeio form research alliance to develop genetic disease solution
Prime and Cimeio form research alliance to develop genetic disease solution
Medical Device Network
Prime Medicine
Cimeio Therapeutics
immunotherapy
genetic diseases
Flag link:
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Globe Newswire
Larkspur Biosciences
immunotherapy
cancer
funding
Flag link:
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
PR Newswire
Myeloid Therapeutics
funding
MRNA
immunotherapy
Flag link:
With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’
With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’
BioPharma Dive
Normunity
immunotherapy
oncology
Flag link:
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
MedCity News
Surge Therapeutics
Harvard
immunotherapy
solid tumors
funding
Flag link:
Using Machine Learning to Predict Immunotherapy Response
Using Machine Learning to Predict Immunotherapy Response
Medical Devices and Diagnostics Industry
machine learning
Medtech
diagnostics
immunotherapy
immune checkpoint inhibitors
artificial intelligence
Flag link:
Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials
Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials
Fierce Biotech
Alladapt Immunotherapeutics
funding
FDA
food allergies
immunotherapy
Flag link:
Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks
Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks
Fierce Biotech
Bristol Myers Squibb
Immatics
SPAC
immunotherapy
drug discovery
biobucks
Flag link:
Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets
Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets
MedCity News
startups
Pheast Therapeutics
Forty Seven
immunotherapy
Flag link:
Bristol Myers scraps $2B Nektar partnership after trial failures
Bristol Myers scraps $2B Nektar partnership after trial failures
BioPharma Dive
Bristol Myers Squibb
Nektar Therapeutics
immunotherapy
Opdivo
kidney cancer
bladder cancer
Flag link:
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
BioSpace
BriaCell
breast cancer
Bria-OTS
immunotherapy
Flag link:
Intellia follows CRISPR peers with deal to explore 'natural killer' cell therapy
Intellia follows CRISPR peers with deal to explore 'natural killer' cell therapy
BioPharma Dive
Intellia Therapeutics
ONK Therapeutics
natural killer cell therapy
immunotherapy
Flag link:
Bristol Myers returns to Immatics for a dual-targeting cancer drug
Bristol Myers returns to Immatics for a dual-targeting cancer drug
BioPharma Dive
Bristol Myers Squibb
Immatics
cancer
immunotherapy
Flag link:
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Flag link:
Biotech Raises $140 Million to Advance iPSC-based Immunotherapies
Biotech Raises $140 Million to Advance iPSC-based Immunotherapies
BioSpace
Shoreline Biosciences
pluripotent stem cells
iPSC
immunotherapy
Flag link:
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
MedCity News
Asher Bio
funding
immunotherapy
cancer immunotherapy
Flag link:
Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway
Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway
Fierce Biotech
Cel-Sci
immunotherapy
clinical trials
head and neck cancer
Multikine
Flag link:

Pages